Posted in Regulatory FDA seeks permanent future for rare pediatric priority review vouchers April 9, 2026 Pharmaceutical Technology The rare disease framework has had a turbulent past few years, with the FDA looking to create regulatory stability. RegulatoryRare DiseaseRead full story